Biomea Fusion Inc.
Clinical trials sponsored by Biomea Fusion Inc., explained in plain language.
-
New diabetes pill shows promise for patients failing ozempic
Disease control Recruiting nowThis study tests a new daily pill, icovamenib, for people with type 2 diabetes whose blood sugar is still too high despite using Ozempic. About 60 adults will receive either the study drug or a placebo for 12 weeks. The main goal is to see if icovamenib lowers HbA1c (a measure of…
Phase: PHASE2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated May 20, 2026 12:08 UTC
-
New diabetes pill shows promise in early trial
Disease control Recruiting nowThis study tests a new medication called icovamenib in people with type 2 diabetes whose blood sugar is not well controlled with their current medicines. About 60 adults will receive either the study drug or a placebo for 12 weeks. The goal is to see if icovamenib can safely lowe…
Phase: PHASE2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated May 18, 2026 12:02 UTC